Top of this page
Skip navigation, go straight to the content

UCB differentiates itself by combining the global infrastructure and expertise of a traditional pharmaceutical company with the speed, innovation and entrepreneurship of a biotech company.

Connecting to our patients' world

At UCB patients are at the heart of everything we do. Since UCB was established in the U.S. in 1994, the U.S. affiliate of UCB has continuously maintained invaluable programs for patients, health care professionals, caregivers and patient communities, in short actively participating in our patients' world. Many of the programs we support are noted for their innovation and pioneering work in health care.

Connecting the business of science

At UCB, we also work on the business of science. U.S. headquarters is based in Atlanta, Georgia and our Research Triangle Park offices in North Carolina are engaged in clinical development.

Working in the U.S.

UCB was established in the U.S. in 1994 through the acquisition of Whitby Pharmaceuticals and Northhampton Medical. UCB acquired Celltech in June 2004, and acquired majority shares of Schwarz Pharma AG in December 2006, enriching UCB product development and pipeline and making it the world's fifth-largest biopharma company. The first UCB biologic product was commercially available soon thereafter in the U.S.

Pictured is the entrance to UCB headquarters in Smyrna, a suburb of Atlanta.